This page is in Beta testing. We welcome your feedback and suggestions as we look to improve this page.
Latest news
Stay informed on our major announcements through our media releases and other updates.
-
-
-
News articles
Read our latest news on regulatory decisions and activities, including product safety and enforcement actions. -
-
Safety updates
Refer to our articles for health professionals about health products and emerging safety issues. -
Health product safety alerts and market actions
See the latest alerts for consumers and health professionals about safety and quality issues with health products.
-
Safety alerts
Refer to the latest safety alerts for medicines or medical devices with possible risks. -
Events and consultations
Have your say on therapeutic goods regulation by participating in our public consultations or browse closed consultations. We also deliver a range of webinars, workshops and meetings on areas of interest for industry, consumers, and health professionals.
-
Consultations
Search open and closed consultations on the way we regulate medicines, medical devices and biologicals. -
Events
Search our upcoming and past events including webinars, committee meetings, presentations, and workshops.
Our subscription services
Stay connected and sign up to our RSS news feeds and email subscription services to receive real-time updates on our latest news, product shortage alerts, and media releases as we publish them, or subscribe to monthly updates.
-
Email subscriptions
We offer several email subscription options to keep you up to date with news and alerts. -
RSS feeds
RSS feeds (Really Simple Syndication feed) for immediate notifications of updates to the TGA website.
Industry notices and compliance undertakings
Notifications for sponsors, manufacturers, and advertisers about official decisions and new or updated regulatory requirements, as well as information about recent regulatory compliance and enforcement actions.
-
Regulatory decision notices
Access official regulatory decisions for sponsors, manufacturers and advertisers, including GMP clearances, listing notices, administrative instruments, and updates to regulatory requirements. -
Latest articles
-
GMP Annex 6 and Annex 15 concept papers - Open for public consultation
News articlesInformation on the recently announced concept papers proposing to update the Good Manufacturing Practice (GMP) guide for Annex 6 and Annex 15. -
Update to listed medicine ingredients in March 2026
Regulatory decision noticesListed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2026, which commenced on 1 March 2026. -
Medicines containing vitamin B6 (pyridoxine, pyridoxal or pyridoxamine)
Safety updatesOral preparations containing more than 50 mg but not more than 200 mg per recommended daily dose of vitamin B6 will be rescheduled as Pharmacist Only Medicines from 1 June 2027.
Latest publications
-
Corporate reportsFind out about the seasonal influenza vaccines available for the 2026 southern hemisphere season.
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 6 November 2025
-
Scheduling decisions (final)This web publication constitutes a notice for the purposes of regulation 42ZCZS of the Therapeutic Goods Regulations 1990 (the Regulations).
Latest consultations
-
ConsultationWe are seeking feedback on proposed changes to Australian medicine labelling rules.
-
ConsultationWe are seeking feedback on proposed amendments relating to transparency of disruptions to supply of a medical device.
-
ConsultationWe are seeking input from stakeholders responsible for developing, deploying or supplying Digital Mental Health Tools (DMHT) to help us better understand these tools.